|
 |
OndansetronThis page contains recent news articles, when available, and an overview of Ondansetron but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Ondansetron (when available) Ondansetron is an antinauseant and antiemetic agent indicated for the prevention of nausea and vomiting associated with moderately-emetogenic cancer chemotherapy and for the prevention of postoperative nausea and vomiting. Ondansetron is a highly specific and selective serotonin 5-HT3 receptor antagonist, not shown to have activity at other known serotonin receptors and with low affinity for dopamine receptors. For treatment of chemotherapy-induced nausea and vomiting Mechanism Of Action: Ondansetron is a selective serotonin 5-HT3 receptor antagonist. The serotonin 5-HT3 receptors are located on the nerve terminals of the vagus in the periphery and centrally in the chemoreceptor trigger zone of the area postrema. It is thought that chemotherapeutic agents produce nausea and vomiting by releasing serotonin from the enterochromaffin cells of the small intestine, and that the released serotonin then activates 5-HT3 receptors located on vagal efferents to initiate the vomiting reflex. Therefore Ondansetron works by blocking the reception of serotonin at these 5-HT3 receptors. News Articles on Ondansetron MonoSol Rx and Strativa Pharmaceuticals Extend Strategic Relationship - 05 Jan 2010 Terms of the new agreements provide the option to license and develop three additional OSF products under a similar structure to the Companies' ondansetron ... PR Newswire (press release) Case 40-2009 — A 29-Year-Old Man with Fever and Respiratory Failure - Dec 23, 2009 Doxycycline, levofloxacin, gentamicin, ibuprofen, acetaminophen, ondansetron, guaifenesin–codeine cough syrup, and ranitidine were administered. ... New England Journal of Medicine (subscription) Can alternatives remedy nausea? - Dec 11, 2009 At this time, I am taking ondansetron and domperidone. Some days I get a little relief. I also take oxycodone, tizanidine, amitriptyline/perphenazine, ... Joliet Herald News No Cardiac Safety Problems When Casopitant Is Given With Anthracycline for ... - Dec 11, 2009 Patients were randomised to receive ondansetron and dexamethasone plus 1 of the following casopitant regimens: single-dose oral casopitant 150 mg/day ... DG News Tesafilm statt Pillen - Dec 20, 2009 Erste Tesa-Medizin ist das Mittel "Ondansetron" eines amerikanischen Pharmakonzerns. Es lindert Brechreiz bei Patienten, die sich einer Chemotherapie ... Welt Online Sulla Gazzetta Ufficiale n. 286 del 9 dicembre 2009 - Dec 10, 2009 Ordinario n.229) Autorizzazione all'immissione in commercio del medicinale per uso umano «Ondansetron Ibigen» (09A14569) (Suppl. Ordinario n.229) cybermed.it SciClone Pharmaceuticals Announces Presentations of SCV-07 Data at Upcoming ... - Nov 12, 2009 The Company also has exclusive commercialization and distribution rights to the anti-nausea drug ondansetron RapidFilmâ„¢ in China and Vietnam, ... CNNMoney.com (press release) Eurand Reports Key Achievements and Strong Revenue Growth for Third Quarter 2009 - Nov 5, 2009 ...a proprietary once-a-day oral modified-release formulation of ondansetron versus an 8 mg dose of the anti-emetic drug Zofran® (ondansetron). ... CNNMoney.com (press release) Acute dystonic reactions in a lady presenting with repetitive involuntary ... - Nov 9, 2009 Her medication on presenting consisted of Ondansetron 8 mg two times a day and Metoclopramide 10 mg three times a day (TDS). She started taking these ... 7thSpace Interactive (press release) Par Pharmaceutical Companies, Inc. - SWOT Analysis - Oct 21, 2009 ...year (FY) ended December 2007, an increase of 6.1% over 2006 primarily due to new product launches and royalties on the sales of ondansetron tablets. ... PRMinds (press release) SciClone Reports Financial Results and Provides Commercial and Pipeline ... - Nov 9, 2009 The Company also has exclusive commercialization and distribution rights to the anti-nausea drug ondansetron RapidFilm(TM) in China and Vietnam, ... CNNMoney.com (press release) www.standoutstocks.com: Stocks That Stand Out For Nov. 13th, 2009 Are HRRN ... - Nov 13, 2009 The Company also has exclusive commercialization and distribution rights to the anti-nausea drug ondansetron RapidFilm(TM) in China and Vietnam, ... Trading Markets (press release) SciClone Pharmaceuticals to Present at Two November Investor Conferences - Nov 4, 2009 The Company also has commercialization and distribution rights to the anti-nausea drug ondansetron RapidFilm(TM) in China and Vietnam, for which it will ... CNNMoney.com (press release) Phase II Failure Forces SciClone to Eliminate 17% of Staff - Oct 28, 2009 The company also has commercialization and distribution rights to the antinausea drug ondansetron RapidFilmâ„¢ in China and Vietnam, for which it is seeking ... Genetic Engineering News (press release) Casopitant reduced chemotherapy-induced vomiting - Oct 21, 2009 All patients were assigned to 8 mg IV dexamethasone on day one and 8 mg oral ondansetron twice daily on days one to three. Compared with 59% in the control ... HemOncToday SciClone Announces Enrollment of First Patient in Its Phase 2 Trial of SCV-07 ... - Oct 24, 2009 The Company also has commercialization and distribution rights to an anti-nausea drug ondansetron RapidFilmTM in China and Vietnam, for which it is seeking ... PR-CANADA.net (press release) é?œè„ˆæ³¨å°„è‘¡è?„ç³–é ?防術後å™?心嘔å?? - Oct 27, 2009 ...他表示，我們使用葡è?„糖快速注射(500 mLçš„5%è‘¡è?„ç³–)ä¾†åŠ å¼·ondansetronå°?於術後å™?心嘔å??的效果，但是我們真的ä¸?知é?“這何以會發生效用。 Tilley醫師指出，水å?ˆä½œç”¨ä¹Ÿå¾ˆ ... 臺灣新浪網 … Natco Pharma gets US FDA nod for Ondansetron; ships 1st consignment - Jun 26, 2007 MUMBAI (Thomson Financial) - India's Natco Pharma Ltd said it has received US Food and Drug Administration (FDA) nod for Ondansetron Hydrochloride tablets ... Forbes Strides Arcolab gets first ANDS approval for Ondansetron - Aug 8, 2007 MUMBAI (Thomson Financial) - Indian pharma company Strides Arcolab Ltd said it received its first Abbreviated New Drug Submission (ANDS) approval for its ... Forbes Pliva says ondansetron hydrochloride gets FDA approval - Nov 21, 2005 LONDON (AFX) - PLIVA said ondansetron hydrochloride (HC1) orally disintegrating tablets (ODT) for treating chemotherapy-associated nausea and vomiting, ... Forbes Dr Reddy's gets USFDA nod for Ondansetron - Dec 28, 2006 Dr Reddy's Laboratories Ltd today got the final approval for Ondansetron Hydrochloride, the generic equivalent of the blockbuster drug `Zofran', ... Hindu Business Line BioAlliance acquires European rights to ondansetron OS from Novadel - May 20, 2008 PARIS (Thomson Financial) - BioAlliance Pharma said it has acquired the European commercial rights to ondansetron Oral Spray (OS), which is being developed ... Forbes India's Strides Arcolab gets ANDA nod from US FDA for Ondansetron … - Apr 24, 2008 Ondansetron, which is used to prevent nausea and vomiting caused by cancer treatments, is licensed to Akorn-Strides, LLC, a joint venture formed in 2004 by ... Forbes Natco Pharma files ANDA for Ondansetron - Oct 4, 2005 Hyderabad-based Natco Pharma Limited has announced the filing of an Abbreviated New Drug Application (ANDA) with US FDA authorities for its product ... Business Standard Natco gets Canadian nod for Ondansetron - Jan 12, 2008 Hyderabad, Jan. 11 Natco Pharma Ltd has bagged the approval of the Canadian Regulatory Agency (TPD-Health Canada), for its product Ondansetron 4 mg and 8 mg ... Hindu Business Line Wockhardt launches Ondansetron in US - Dec 28, 2006 Wockhardt's US subsidiary, Wockhardt USA, has launched Ondansetron injection in the United States on December 26. Ondansetron is the generic version of ... Business Standard Strides Arcolab gets US nod for ondansetron injection - Apr 24, 2008 MUMBAI, April 24 (Reuters) - Strides Arcolab Ltd (STAR.BO: Quote, Profile, Research) said on Thursday the US Food and Drug Administration had approved two ... Reuters India Mylan gets final approval for generic version of Glaxo drug - Jun 25, 2007 Mylan said the US Food and Drug Administration approved its applications for different strengths of ondansetron hydrochloride tablets and ondansetron orally ... Reuters … Receives Tentative FDA Approvals For Ondansetron Injection In... - Jun 15, 2006 DEERFIELD, Ill., June 15 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation today announced that it has received tentative approvals from the US Food ... Free with registration - PR Newswire - AccessMyLibrary.com Mylan wins tentative FDA approval for Zofran generic - Feb 26, 2007 Ondansetron tablets are the generic version of GlaxoSmithKline Plc's (GSK.L) Zofran tablets, the company said in a statement. ... Reuters Study finds antivomit drug helps, overused - Apr 20, 2006 ...''Children who received Ondansetron had fewer episodes of vomiting, greater oral intake of fluids, and a shorter stay in the emergency department," said the ... Boston Globe Granisetron and Ondansetron for Prevention of Nausea and Vomiting in ... - Jan 8, 2005 Modified radical mastectomy is associated with a relatively high incidence of postoperative nausea and vomiting (PONV). This study was undertaken to ... RedOrbit India's Cipla, Glenmark get tentative FDA nods - Feb 9, 2007 BO) has received tentative approval for ondansetron hydrochloride tablets, which is used in controlling nausea and vomiting caused by chemotherapy. ... Reuters … Tentative ANDA Approvals For Carvedilol Tablets and Ondansetron... - Apr 24, 2006 The FDA has determined that Taro's ondansetron is safe and effective for use when ... Ondansetron is a prescription pharmaceutical product used for the ... primezone.com Ondansetron Therapy May Improve Outcomes in Children With … - Sep 2, 2008 September 2, 2008 — Ondansetron therapy decreases the risk for persistent vomiting, the use of intravenous fluid, and hospital admissions in children ... Medscape … Pharmacokinetic Study Results of Ondansetron Lingual Spray; *... - Mar 16, 2005 We look forward to moving ondansetron lingual spray into pivotal trials this year," ... Plasma ondansetron levels were measured and analyzed for standard ... Free with registration - PR Newswire - AccessMyLibrary.com Glenmark receives approval for Ondansetron IR & ODT tablets - Jun 29, 2007 Glenmark Pharmaceuticals Ltd. [Glenmark], a research-based pharmaceutical company, headquartered in Mumbai (India), has received final approval from the US ... Moneycontrol.com Par Pharmaceutical (PRX) Receives Final FDA Approval for Ondansetron ... - Dec 26, 2006 Ondansetron ODT is the generic version of GlaxoSmithKline's (NYSE: GSK) Zofran ODT. The product is used for the prevention of nausea and vomiting associated ... StreetInsider.com - StreetInsider.com (subscription) Ondansetron reduces vomiting, hospital admissions in children with … - Sep 6, 2008 New technique could eliminate inherited mitochondrial disease — [26 Aug 2009] — Researchers have developed an experimental technique with the potential to ... Science Centric NATCO PHARMA FILES ANDA FOR ONDANSETRON - Oct 3, 2005 Natco Pharma Ltd., has announced the filing of an Abbreviated New Drug Application (ANDA) with US FDA authorities for its product - Ondansetron ... Pay-Per-View - Hindustan Times - Factiva, from Dow Jones … with Shanghai Ethypharm to Market Ondansetron Once Approved in Chin - Jul 19, 2007 ..."Ondansetron is a significant global product that complements our plans in ... Ondansetron is the generic form of Zofran(R), the global leader in the ... Genetic Engineering News - Genetic Engineering News (press release) Drug Kicks Cocaine Addiction - May 23, 2006 Researchers found the drug ondansetron, the generic name for GlaxoSmithKline's ... “These preliminary findings suggest that ondansetron, in combination with ... Red Herring Generic sales inject more profits for Dr Reddy's - Jan 23, 2007 The 180-day marketing exclusivity gained for Ondansetron, the generic version of Zofran ... Ondansetron, is the second drug gaining marketing exclusivity, ... Hindu Business Line Young cervical cancer victim denied £7-a-day treatment - because it's... - Aug 27, 2008 Her oncologist prescribed her the anti-nausea drug Ondansetron to combat the daily ... However, the Ondansetron tablets have helped her regain some of the ... Daily Mail Ondansetron reduces drinking in adolescents with alcohol dependence.(... - Dec 1, 2005 The serotonin-3 antagonist ondansetron may be useful in treating alcohol dependence in adolescents, according to research published in the journal Addictive ... Free with registration - Brown University Digest of Addiction... - AccessMyLibrary.com Glenmark gets US nod for nausea drug - Sep 20, 2006 Ondansetron Hydrochloride is the generic version of GlaxoSmithKline's Zofram tablets and the drug had an annual sales of about $640 million, ... Hindu Business Line Dr Reddy's: good guidance, but headwinds remain - May 22, 2008 Dr Reddy's Laboratories Ltd was not expected to grow in the fourth quarter because there were no exclusive revenues from its anti-emetic ondansetron, ... Livemint Abraxis BioScience Launches Ondansetron Injection, USP. - Jan 4, 2007 LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ: ABBI), an integrated, global biopharmaceutical company, today announced that it has launched Ondansetron ... Free with registration - Business Wire - AccessMyLibrary.com Marinol(R) Helps to Reduce Delayed Chemotherapy-Induced Nausea … - May 16, 2005 For total response, MARINOL(R) was comparable to ondansetron at endpoint (54 ... Total response to ondansetron was significantly better than placebo (20 ... Medical News Today - Medical News Today (press release) Teva Announces Tentative Approval of Ondansetron Injection USP. - Feb 26, 2006 JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that the US Food and Drug Administration has granted tentative approval for ... Free with registration - Business Wire - AccessMyLibrary.com NovaDel Announces European License Agreement for Ondansetron Oral … - May 21, 2008 NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, ... Nanotechnology News - Nanotechnology News (press release) FDA approves first generic ondansetron.(Food and Drug Administration)(... - Jan 8, 2007 The US Food and Drug Administration has approved the first generic versions of GlaxoSmithKline's Zofran (ondansetron) Tablets, orally-disintegrating tablets ... Free with registration - Pharma Marketletter - AccessMyLibrary.com … Pivotal Trials of Zensana(TM), First Proprietary Ondansetron Oral... - Mar 9, 2006 Zensana(TM) delivers full doses of ondansetron to patients receiving emetogenic ... Ondansetron is approved to prevent chemotherapy and radiation-induced, ... Free with registration - Business Wire - AccessMyLibrary.com … Announces Positive Pharmacokinetic Study Results of Ondansetron … - Mar 16, 2005 We look forward to moving ondansetron lingual spray into pivotal trials this year," ... Plasma ondansetron levels were measured and analyzed for standard ... Pay-Per-View - PR Newswire - HighBeam Research Colorectal Cancer,Metastatic or Recurrent - Medications - Oct 1, 2008 Aprepitant (Emend), which is used in combination with ondansetron and dexamethasone as part of a ... Serotonin antagonists, such as ondansetron (Zofran), ... WebMD Dr Reddy`s: Going strong - May 23, 2007 In the company's generics division, the sales of high-margin ondansetron, which was launched in late December 2006, helped the segment revenues grow 326 per ... Business Standard Man takes drastic action for drugs - Apr 21, 2006 Pharmac says ondansetron is available on prescription to outpatients under exceptional circumstances. They'll consider whether Joanne's situation meets ... TVNZ … Delivery; Positive pharmacokinetic study results reported for... - Apr 12, 2005 We look forward to moving ondansetron lingual spray into pivotal trials this year," ... Plasma ondansetron levels were measured and analyzed for standard ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Natco drug gets USFDA nod - Jun 27, 2007 Ondansetron Hydrochloride is a popular anti-emetic, commonly used by cancer patients. The market for Ondansetron generics, all over the US is expected to be ... Hindu Business Line … SA complements its portfolio with a European license for ondansetro... - Aug 4, 2008 Ondansetron thin film formulation is a new oral formulation for the prevention of ... Ondansetron was the prescription leader in the category in 2007, ... marketwire.com Sun Pharma, Cipla get tentative nod for drug: Rediff.com news - May 23, 2006 Ondansetron is used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, anesthesia and surgery. The USFDA has also given tentative ... Rediff … Delivery; Positive pharmacokinetic study results reported for... - Apr 15, 2005 We look forward to moving ondansetron lingual spray into pivotal trials this year," ... Plasma ondansetron levels were measured and analyzed for standard ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Teva's ondansetron ANDA approved.(Abbreviated New Drug Applications … - Jul 2, 2007 Israel-headquartered generics giant Teva Pharmaceutical Industries says that the US Food and Drug Administration has granted approval for its Abbreviated ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Ondansetron May Ease Children's Gastroenteritis - Sep 3, 2008 CHAPEL HILL, NC — University of North Carolina at Chapel Hill researchers have demonstrated that a drug called ondansetron may reduce vomiting, ... EndoNurse IN BRIEF / PHARMACEUTICALS; Teva gets approval to sell generic anti- ... - Nov 23, 2006 The Food and Drug Administration approved Teva's application to sell the drug ondansetron, which is a generic version of GlaxoSmithKline's Zofran. ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Hana Bio's Zofran rival enters new trial - Feb 10, 2005 Ondansetron belongs to a class of drugs known as 5HT3 antagonists that are widely used to prevent chemotherapy-induced nausea and vomiting. ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones NovaDel's European Formulation of Ondansetron Targeted for US … - Mar 23, 2007 FLEMINGTON, NJ -- NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations of a broad range of marketed ... Free with registration - Business Wire - AccessMyLibrary.com Ondansetron reduces vomiting, hospital admissions in children with … - Sep 2, 2008 University of North Carolina at Chapel Hill researchers have demonstrated that a drug called ondansetron helps reduce vomiting, the need for intravenous ... PhysOrg.com Hana Biosciences Presents Zensana(TM) (ondansetron HCl) Oral Spray … - May 31, 2006 ...-- Completion of pivotal trials confirmed Zensana(TM) (ondansetron HCl) Oral Spray 8 mg dose is statistically bioequivalent to the current commercially ... Genetic Engineering News - Genetic Engineering News (press release) … Thin Film Formulation of Ondansetron to Strativa Pharmaceuticals,... - Jun 17, 2008 WARREN, NJ and PORTAGE, Ind., June 17 /PRNewswire/ -- MonoSol Rx, a drug delivery company specializing in dissolving thin film pharmaceutical products, ... RedOrbit Hana Biosciences to get up to $50M in license deal - Aug 1, 2007 Zensana delivers ondansetron, a standard antiemetic therapy that is used in the prevention of nausea and vomiting as a result of chemotherapy, radiation, ... Bizjournals.com FDA CAPSULES - Dec 5, 2006 FDA APPROVES FIRST GENERIC ONDANSETRON INJECTION. The U.S. Food and Drug Administration has approved first generic versions of Zofran (Ondansetron) ... Pay-Per-View - Newsday - ProQuest Archiver Ondansetron injection (Zofran, GlaxoSmithKline) received approval for... - May 1, 2005 Ondansetron injection (Zofran, GlaxoSmithKline) received approval for the prevention of nausea and vomiting associated with general anesthesia in children ... Free with registration - Formulary - AccessMyLibrary.com … Nausea and Vomiting Better Than Ondansetron: Presented at ACOG - May 9, 2007 In the study, the 40 mg dose of aprepitant achieved statistically significant advantages over ondansetron in all five endpoints, reported Keith Candiotti, ... DG News Dexamethasone Improves Ondansetron"s Prevention of Radiation- … - Aug 9, 2006 NEW YORK AUG 09, 2006 (Reuters Health) - The addition of dexamethasone to ondansetron somewhat improves prophylaxis against radiation-induced emesis (RIE), ... Cancerpage.com … Receives FDA Approval For Ondansetron Hydrochloride Injection USP,... - Mar 28, 2008 Taro Pharmaceutical Industries Ltd. ("Taro," the "Company," Pink Sheets: TAROF) reported that it has received approval from the US Food and Drug ... Medical News Today - Medical News Today (press release) … Results from Its Second 24 Hour CDT-Ondansetron Trial.(Financial... - Feb 6, 2007 Ondansetron hydrochloride is the active ingredient in Zofran[R], GlaxoSmithKline's drug ... The results from our ondansetron study further demonstrate the ... Free with registration - Business Wire - AccessMyLibrary.com Learn about Ondansetron Injection from Consumer Reports Health. - Jan 1, 2007 Ondansetron injection is used to prevent nausea and vomiting caused by cancer chemotherapy and surgery. Ondansetron is in a class of medications called ... consumerreports.org Hospira Launches Ondansetron Injection. - Dec 26, 2006 LAKE FOREST, Ill., Dec. 26 /PRNewswire-FirstCall/ -- Hospira, Inc. , a leading global hospital products company, today announced the launch of ondansetron ... Free with registration - PR Newswire - AccessMyLibrary.com … Receives FDA Approval for Ondansetron Hydrochloride Injection USP,... - Mar 25, 2008 Taro Pharmaceutical Industries Ltd. ("Taro," the "Company," Pink Sheets: TAROF) reported today that it has received approval from the US Food and Drug ... Genetic Engineering News - Genetic Engineering News (press release) Ondansetron Effective for Gastroenteritis with Vomiting - Sep 1, 2006 Synopsis: Although oral rehydration is the treatment of choice for children with gastroenteritis, it can be a challenge when the child cannot keep anything ... AAFP News Now New Class of Drug Reduces Post Operative Vomiting - Oct 26, 2005 The currently used drugs, like ondansetron, block signals in the gut and chemoreceptor trigger zone (CTZ), which is located in the brainstem. ... emaxhealth.com Learn about Ondansetron from Consumer Reports Health. - Jan 1, 2007 Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy and surgery. Ondansetron is in a class of medications ... consumerreports.org … Partners Receives Two Tentative FDA Approvals for Ondansetron … - Mar 9, 2006 According to IMS, sales in 2005 of ondansetron in the United States ... APP expects to receive final approval and commence marketing ondansetron upon patent ... RedOrbit … Receives Tentative FDA Approvals For Ondansetron Injection In... - Jun 15, 2006 Baxter Receives Tentative FDA Approvals For Ondansetron Injection In Vials And Premix Containers. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Ondansetron is effective for gastroenteritis with vomiting in... - Aug 1, 2006 Bottom line Ondansetron given to children who are mildly to moderately dehydrated because of diarrhea and vomiting improves their ability to comply with ... Free with registration - JAAPA-Journal of the American Academy... - AccessMyLibrary.com Hana Biosciences Submits Zensana(TM) (ondansetron HCl) Oral Spray … - Jun 30, 2006 Hana Biosciences (NASDAQ:HNAB), a biopharmaceutical company focused on advancing cancer care, today announced that the company has submitted a New Drug ... Genetic Engineering News - Genetic Engineering News (press release) First-time generic approval of ondansetron (Zofran).(From the... - Mar 1, 2007 Ondansetron is indicated for the prevention of nausea and vomiting associated ... A serotonin antagonist, ondansetron is also used off-label for treating ... Free with registration - Brown University Geriatric Psychopharmac... - AccessMyLibrary.com FDA APPROVES TEVA'S GENERIC ONDANSETRON INJECTION - Nov 28, 2006 Teva Pharmaceutical Industries announced that the FDA has granted final approval to its abbreviated new drug applications for the first generic versions of ... Pay-Per-View - FDAnews Drug Pipeline Alert - Factiva, from Dow Jones FDA Approves First Generic Ondansetron Injection - Nov 24, 2006 The US Food and Drug Administration (FDA) today approved first generic versions of Zofran (Ondansetron) Injection and Zofran (Ondansetron) Injection ... Kansas City infoZine SCOLR Commences CDT(R)-Ondansetron and Phenylephrine Testing - Oct 24, 2006 SCOLR Pharma, Inc. (AMEX: DDD) announced today that it has initiated pilot bioavailability testing in Canada of its refined once-daily CDT(R)-ondansetron ... Genetic Engineering News - Genetic Engineering News (press release) … FDA Approval for Ondansetron Hydrochloride Tablets and Ondansetron... - Jun 25, 2007 Mylan Announces Final FDA Approval for Ondansetron Hydrochloride Tablets and Ondansetron Orally Disintegrating Tablets, USP. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Tentative OK for Teva's ondansetron.(Teva Pharmaceutical Industries... - Mar 6, 2006 Israel's Teva Pharmaceutical Industries says that it has received tentative approval from the US Food and Drug Administration for its Abbreviated New Drug ... $4.95 - Pharma Marketletter - ECNext How to take Ondansetron from Consumer Reports Health. - Jan 1, 2007 ...tell your doctor and pharmacist if you are allergic to ondansetron, alosetron (Lotronex), dolasetron (Anzemet), granisetron (Kytril), palonosetron (Aloxi), ... consumerreports.org … Filing of NDA for the Zensana(TM) (Ondansetron HCl) Oral Spray. - Jul 5, 2006 Zensana(TM) (ondansetron HCl) Oral Spray is the first oral spray 5-HT3 antagonist that ... Ondansetron, a selective blocking agent of the hormone serotonin, ... Free with registration - Business Wire - AccessMyLibrary.com Bedford Laboratories(TM) to Begin Shipping Ondansetron Injection USP - Dec 26, 2006 BEDFORD, Ohio, Dec. 26 /PRNewswire/ -- Bedford Laboratories(TM), a division of Ben Venue Laboratories Inc., announced that it will begin marketing ... Genetic Engineering News - Genetic Engineering News (press release) … Pivotal Bioequivalence Studies for Ondansetron Thin Film NDA. - Dec 2, 2008 MonoSol Rx Successfully Completes Pivotal Bioequivalence Studies for Ondansetron Thin Film NDA. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Teva Announces Approval of Ondansetron - Jun 27, 2007 Teva Pharmaceutical announced that the FDA granted approval for the company's abbreviated new drug applications to market Ondansetron Hydrochloride (HCl) ... FDA news - FDA news (subscription) Wockhardt launches Ondansetron Injection in US - Jan 31, 2007 Wockhardt's US subsidiary has launched Ondansetron Injection in the United States, the first working day after the patent for the product expired on ... Express Pharma Abraxis BioScience Launches Ondansetron Injection, USP - Jan 3, 2007 Abraxis BioScience, Inc. (NASDAQ: ABBI), an integrated, global biopharmaceutical company, today announced that it has launched Ondansetron Injection, USP, ... Genetic Engineering News - Genetic Engineering News (press release) Taking Ondansetron Injection from Consumer Reports Health. - Jan 1, 2007 Ondansetron may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:. Some side effects can be serious. ... consumerreports.org NovaDel Comments on Delay in Zensana(TM) Launch, as Announced by … - Feb 20, 2007 Zensana(TM) is an oral spray formulation of ondansetron that is indicated ... "We also believe that the ondansetron manufacturing issue is not indicative of ... Genetic Engineering News - Genetic Engineering News (press release) … Tentative Approval for Ondansetron Hydrochloride Tablets. - PR … - Aug 26, 2005 Mylan Announces Tentative Approval for Ondansetron Hydrochloride Tablets. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Actavis launches generic ondansetron in USA.(Brief article) - Jul 9, 2007 Iceland-headquartered generic drug group Actavis says that it has launched its ondansetron tablets in the US Actavis will market the product under an ... Free with registration - Pharma Marketletter - AccessMyLibrary.com First-time generic approval of ondansetron.(From the FDA)(Brief... - Apr 1, 2007 Final approval has been granted for a first generic version of Zofran (ondansetron) tablets, orally disintegrating tablets, and oral solution. ... Free with registration - Brown University Psychopharmacology... - AccessMyLibrary.com FDA Approves First Generic Ondansetron Tablets, Orally Disintegrating... - Jan 4, 2007 The Food and Drug Administration today approved the first generic versions of Zofran (Ondansetron) Tablets, Orally Disintegrating Tablets and Oral Solution ... Medical News Today - Medical News Today (press release) Glenmark gets tentative approval for Ondansetron - Oct 31, 2006 Glenmark Pharmaceuticals, USA has received tentative approval from the USFDA for its ANDA for Ondansetron Hydrochloride Tablets of four milligram (base), ... Express Pharma Sun Pharma gets tentative US FDA approval for Ondansetron. - Jul 24, 2006 Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, anaesthesia, and surgery. Free with registration - PTI - The Press Trust of India Ltd - AccessMyLibrary.com Ondansetron.(NEW GENERICS)(Brief article) - Jan 22, 2007 The FDA has approved the first generic versions of ondansetron tablets, orally disintegrating tablets, and oral solution. The drug is indicated for the ... $4.95 - Drug Topics - ECNext Ondansetron. - Jan 22, 2007 The FDA has approved the first generic versions of ondansetron tablets, orally disintegrating tablets, and oral solution. The drug is indicated for the ... $9.94 - Drug Topics - Alacra Store … Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study. -... - Feb 21, 2008 MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … FDA Approval for Ondansetron Hydrochloride Tablets and Ondansetron... - Jun 25, 2007 PITTSBURGH, June 25 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. today announced that Mylan Pharmaceuticals Inc. has received final approval from the ... $4.95 - PR Newswire - ECNext Press Release: Barr's Subsidiary PLIVA Launches Ondansetron 4 mg and … - Dec 26, 2006 Barr's Subsidiary PLIVA Launches Ondansetron 4 mg and 8 mg Orally Disintegrating Tablets. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Ondansetron may curb vomiting in gastroenteritis.(Infectious Diseases)... - Oct 1, 2008 Ondansetron may curb vomiting in gastroenteritis.(Infectious Diseases) ... find Pediatric News articles. Ondansetron therapy effectively reduced vomiting ... Pay-Per-View - Pediatric News - HighBeam Research FDA approves first generic Ondansetron tablets.(Industry News) - Feb 1, 2007 The FDA has approved the first generic versions of Zofran (Ondansetron) Tablets, Orally Disintegrating Tablets and Oral Solution which are indicated to ... Free with registration - Pharmaceutical Processing - AccessMyLibrary.com Dr Reddy's gets USFDA nod for Ondansetron - Dec 28, 2006 Dr Reddy's Laboratories Ltd today got the final approval for Ondansetron Hydrochloride, the generic equivalent of the blockbuster drug `Zofran', ... Moneycontrol.com Generic Ondansetron injection approved. - Nov 27, 2006 WASHINGTON, Nov. 27 (UPI) -- The US Food and Drug Administration has approved the first generic versions of Zofran (ondansetron) injection and injection ... Free with registration - UPI NewsTrack - AccessMyLibrary.com Brand Names/Synonyms: Ondansetron is also known by the following brand names and/or synonymsZophren; Zofran; Zudan; Zofran ODT Drug Category: Ondansetron is categorized under the following by the FDA: Anti-anxiety Agents; Antipsychotics; Antipruritics; Antiemetics; Serotonin Antagonists; ATC:A04AA01 Dosage Forms: TABLET; LIQUID Absorption: Ondansetron is well absorbed after oral administration and undergoes limited first-pass metabolism. Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydrocarbazol-4-one |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
